Expression of major histocompatibility complex (MHC) class I alleles such as B*57 and B*27 are associated with slow HIV disease progression. HIV-specific immune responses in slow progressors (SP) are characterized by a poly-functional profile. We previously observed within infected subjects that HIV peptide-specific responses could differ from each other in their functional composition. We investigate here whether responses restricted by MHC class I alleles associated with slow disease progression have a more poly-functional profile than responses restricted by other alleles. We stimulated peripheral blood mononuclear cells (PBMCs) isolated from 36 chronically HIV-infected individuals with a panel of optimal peptides restricted by the HLA alleles expressed by each subject, and assessed the contribution of single IL-2-, single IFN-γ-, and IFN-γ/IL-2-secreting lymphocytes to the total response measured using a dual color ELISPOT assay. The contribution of functional subsets to responses restricted by HLA B*57/B*27 was similar in SP and progressors. For responses restricted by other MHC class I alleles, dual IFN-γ/IL-2-secreting lymphocytes contributed significantly more to the total response in SP than progressors. Within SP subjects, peptides restricted by both B*57/B*27 and other alleles stimulated responses with similar functional profiles. In progressors, peptides restricted by B*57/B*27 stimulated responses composed of a significantly greater proportion of IFN-γ/IL-2-secreting cells than peptides restricted by other alleles. Within progressors, the contribution of IFN-γ/IL-2-secreting lymphocytes was greater to epitopes restricted by protective HLA alleles compared with responses restricted by other alleles. HLA haplotypes influence the relative functional composition of HIV-specific responses.
Get full access to this article
View all access options for this article.
References
1.
AddoMM, YuXG, RathodA, CohenDet al.Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load. J Virol, 2003; 77:2081–2092.
2.
AlmeidaJR, PriceDA, PapagnoLet al.Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover. J Exp Med, 2007; 204:2473–2485.
3.
AltfeldM, KalifeE, QiYet al.HLA alleles associated with delayed progression to AIDS contribute strongly to the initial CD8(+) T cell response against HIV-1. PLoS Med, 2006; 3:e403.
4.
AltfeldM, KalifeET, QiYet al.HLA alleles associated with delayed progression to AIDS contribute strongly to the initial CD8(+) T cell response against HIV-1. PLoS Med, 2006; 3:e403.
BoulasselMR, SpurllG, RouleauDet al.Changes in immunological and virological parameters in HIV-1 infected subjects following leukapheresis. J Clin Apher, 2003; 18:55–60.
7.
BouletS, NdongalaML, PeretzYet al.A dual color ELISPOT method for the simultaneous detection of IL-2 and IFN-gamma HIV-specific immune responses. J Immunol Methods, 2007; 320:18–29.
8.
BranderC, KorberBT, WalkerBet al.Recent advances in the optimization of HIV-specific CTL epitopes in the HIV Molecular Immunology Database. Los Alamos National Laboratory: Theoretical Biology and Biophysics: Los Alamos, NM.
9.
BrockmanMA, BrummeZL, BrummeCJet al.Early selection in Gag by protective HLA alleles contributes to reduced HIV-1 replication capacity that may be largely compensated for in chronic infection. J Virol, 2010; 84:11937–11949. doi:JVI.01086-10[pii];10.1128/JVI.01086-10[doi].
10.
BuchbinderS, VittinghoffE. HIV-infected long-term nonprogressors: epidemiology, mechanisms of delayed progression, and clinical and research implications. Microbes Infect, 1999; 1:1113–1120.
11.
CarringtonM, NelsonGW, MartinMPet al.HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. Science, 1999; 283:1748–1752.
12.
CarringtonM, O'BrienSJ. The influence of HLA genotype on AIDS. Annu Rev Med, 2003; 54:535–551.
13.
DarrahPA, PatelDT, De LucaPMet al.Multifunctional Th1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat Med, 2007; 13:843–850.
14.
DraenertR, VerrillCL, TangYet al.Persistent recognition of autologous virus by high-avidity CD8 T cells in chronic, progressive human immunodeficiency virus type 1 infection. J Virol, 2004; 78:630–641.
15.
FellayJ, ShiannaKV, GeDet al.A whole-genome association study of major determinants for host control of HIV-1. Science, 2007; 317:944–947.
16.
FrahmN, KorberBT, AdamsCMet al.Consistent cytotoxic-T-lymphocyte targeting of immunodominant regions in human immunodeficiency virus across multiple ethnicities. J Virol, 2004; 78:2187–2200.
17.
FraterAJ, BrownH, OxeniusAet al.Effective T-cell responses select human immunodeficiency virus mutants and slow disease progression. J Virol, 2007; 81:6742–6751.
18.
GeldmacherC, CurrierJR, HerrmannEet al.CD8 T-cell recognition of multiple epitopes within specific Gag regions is associated with maintenance of a low steady-state viremia in human immunodeficiency virus type 1-seropositive patients. J Virol, 2007; 81:2440–2448.
19.
GoulderPJ, BunceM, KrausaPet al.Novel, cross-restricted, conserved, and immunodominant cytotoxic T lymphocyte epitopes in slow progressors in HIV type 1 infection. AIDS Res Hum Retroviruses, 1996; 12:1691–1698.
20.
HarariA, DutoitV, CelleraiC, BartPA, Du PasquierRA, PantaleoG. Functional signatures of protective antiviral T-cell immunity in human virus infections. Immunol Rev, 2006; 211:236–254.
21.
HarariA, PetitpierreS, VallelianF, PantaleoG. Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1-infected subjects with progressive disease: changes after antiretroviral therapy. Blood, 2004; 103:966–972.
22.
HendelH, Caillat-ZucmanS, LebuanecHet al.New class I and II HLA alleles strongly associated with opposite patterns of progression to AIDS. J Immunol, 1999; 162:6942–6946.
23.
HerspergerAR, PereyraF, NasonMet al.Perforin expression directly ex vivo by HIV-specific CD8 T-cells is a correlate of HIV elite control. PLoS Pathog, 2010; 6:e1000917, doi:10.1371/journal.ppat.1000917[doi].
24.
HoneyborneI, PrendergastA, PereyraFet al.Control of human immunodeficiency virus type 1 is associated with HLA-B*13 and targeting of multiple gag-specific CD8+ T-cell epitopes. J Virol, 2007; 81:3667–3672.
HortonH, FrankI, BaydoRet al.Preservation of T cell proliferation restricted by protective HLA alleles is critical for immune control of HIV-1 infection. J Immunol, 2006; 177:7406–7415.
27.
JansenCA, KostenseS, VandenbergheKet al.High responsiveness of HLA-B57-restricted Gag-specific CD8+ T cells in vitro may contribute to the protective effect of HLA-B57 in HIV-infection. Eur J Immunol, 2005; 35:150–158.
28.
KaslowRA, CarringtonM, AppleRet al.Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat Med, 1996; 2:405–411.
29.
KaufmannDE, BaileyPM, SidneyJet al.Comprehensive analysis of human immunodeficiency virus type 1-specific CD4 responses reveals marked immunodominance of gag and nef and the presence of broadly recognized peptides. J Virol, 2004; 78:4463–4477.
30.
KiepielaP, NgumbelaK, ThobakgaleCet al.CD8(+) T-cell responses to different HIV proteins have discordant associations with viral load. Nat Med, 2006; 13:46–53.
31.
LeslieA, PriceDA, MkhizePet al.Differential selection pressure exerted on HIV by CTL targeting identical epitopes but restricted by distinct HLA alleles from the same HLA supertype. J Immunol, 2006; 177:4699–4708.
32.
LichterfeldM, YuXG, WaringMTet al.HIV-1-specific cytotoxicity is preferentially mediated by a subset of CD8(+) T cells producing both interferon-gamma and tumor necrosis factor-alpha. Blood, 2004; 104:487–494.
33.
MacDonaldKS, FowkeKR, KimaniJet al.Influence of HLA supertypes on susceptibility and resistance to human immunodeficiency virus type 1 infection. J Infect Dis, 2000; 181:1581–1589.
34.
MasemolaA, MashishiT, KhouryGet al.Hierarchical targeting of subtype C human immunodeficiency virus type 1 proteins by CD8+ T cells: correlation with viral load. J Virol, 2004; 78:3233–3243.
35.
McNeilAJ, YapPL, GoreSMet al.Association of HLA types A1-B8-DR3 and B27 with rapid and slow progression of HIV disease. QJM, 1996; 89:177–185.
36.
MiguelesSA, LaboricoAC, ShupertWLet al.HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nat Immunol, 2002; 3:1061–1068.
37.
MiguelesSA, OsborneCM, RoyceCet al.Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune control. Immunity, 2008; 29:1009–1021. doi:S1074-7613(08)00501-3[pii];10.1016/j.immuni.2008.10.010[doi].
38.
MiguelesSA, SabbaghianMS, ShupertWLet al.HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. Proc Natl Acad Sci USA, 2000; 97:2709–2714.
39.
NdongalaML, PeretzY, BouletSet al.HIV Gag p24 specific responses secreting IFN-gamma and/or IL-2 in treatment-naive individuals in acute infection early disease (AIED) are associated with low viral load. Clin Immunol, 2009; 131:277–287. doi:S1521-6616(08)00912-1[pii];10.1016/j.clim.2008.11.006[doi].
40.
O'BrienSJ, GaoX, CarringtonM. HLA and AIDS: a cautionary tale. Trends Mol Med, 2001; 7:379–381.
41.
PalmerBE, BoritzE, WilsonCC. Effects of sustained HIV-1 plasma viremia on HIV-1 gag-specific CD4+ T cell maturation and function. J Immunol, 2004; 172:3337–3347.
42.
PantaleoG, HarariA. Functional signatures in antiviral T-cell immunity for monitoring virus-associated diseases. Nat Rev Immunol, 2006; 6:417–423.
43.
PeretzY, AlterG, BoisvertMP, HatzakisG, TsoukasCM, BernardNF. Human immunodeficiency virus (HIV)-specific gamma interferon secretion directed against all expressed HIV genes: relationship to rate of CD4 decline. J Virol, 2005; 79:4908–4917.
44.
PeretzY, NdongalaML, BouletSet al.Functional T cell subsets contribute differentially to HIV peptide-specific responses within infected individuals: Correlation of these functional T cell subsets with markers of disease progression. Clin Immunol, 2007; 124:57–68.
45.
SachaJB, ChungC, RakaszEGet al.Gag-specific CD8+ T lymphocytes recognize infected cells Before AIDS-virus integration and viral protein expression. J Immunol, 2007; 178:2746–2754.
46.
SchererA, FraterJ, OxeniusAet al.Quantifiable cytotoxic T lymphocyte responses and HLA-related risk of progression to AIDS. Proc Natl Acad Sci USA, 2004; 101:12266–12270.
47.
StreeckH, JolinJS, QiYet al.Human immunodeficiency virus type 1-specific CD8+ T-cell responses during primary infection are major determinants of the viral set point and loss of CD4+ T cells. J Virol, 2009; 83:7641–7648. doi:JVI.00182-09[pii];10.1128/JVI.00182-09[doi].
48.
StreeckH, LichterfeldM, AlterGet al.Recognition of a defined region within p24 gag by CD8+ T cells during primary human immunodeficiency virus type 1 infection in individuals expressing protective HLA class I alleles. J Virol, 2007; 81:7725–7731.
49.
TangJ, CostelloC, KeetIPet al.HLA class I homozygosity accelerates disease progression in human immunodeficiency virus type 1 infection. AIDS Res Hum Retroviruses, 1999; 15:317–324.
UenoT, IdegamiY, MotozonoC, OkaS, TakiguchiM. Altering effects of antigenic variations in HIV-1 on antiviral effectiveness of HIV-specific CTLs. J Immunol, 2007; 178:5513–5523.
52.
YounesSA, Yassine-DiabB, DumontAR, BoulasselMR, GrossmanZ, RoutyJP, SekalyRP. HIV-1 viremia prevents the establishment of interleukin 2-producing HIV-specific memory CD4+ T cells endowed with proliferative capacity. J Exp Med, 2003; 198:1909–1922.
53.
ZimmerliSC, HarariA, CelleraiC, VallelianF, BartPA, PantaleoG. HIV-1-specific IFN-gamma/IL-2-secreting CD8 T cells support CD4-independent proliferation of HIV-1-specific CD8 T cells. Proc Natl Acad Sci USA, 2005; 102:7239–7244.
54.
ZimmerliSC, HarariA, CelleraiC, VallelianF, BartPA, PantaleoG. HIV-1-specific IFN-gamma/IL-2-secreting CD8 T cells support CD4-independent proliferation of HIV-1-specific CD8 T cells. Proc Natl Acad Sci USA, 2005; 102:7239–7244.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
